← Open Payments lookup

JAMES KLINE: Open Payments

NPI 1811960347 · WYOMISSING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$10,870 in 163 payments from 23 companies in 2025. Trend: 2023 $2,439 · 2024 $5,613 · 2025 $10,870

Speaker / faculty: $5,535Food & beverage: $3,389Consulting: $1,080Travel & lodging: $768Education: $99
CompanyPaymentsAmount
Madrigal Pharmaceuticals25$7,480
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$684
ABBVIE INC.39$478
Takeda Pharmaceuticals U.S.A., Inc.17$319
Janssen Biotech, Inc.10$303
PFIZER INC.15$274
Ardelyx, Inc.7$262
GENZYME CORPORATION7$170
Gilead Sciences, Inc.3$169
Regeneron Healthcare Solutions, Inc.7$139

Products named: REZDIFFRA, XIFAXAN, DUPIXENT, TREMFYA, IBSRELA, ENTYVIO, VELSIPITY, CREON.

Industry payments across PA — which companies pay providers there.